The administration, which is set to cut the subsidy for the drug benefit program by 40%, says it will negotiate with insurers to ease the financial strain to the millions of seniors on the plan. Plus, ...

UnitedHealth shares continue to struggle after the company issued a fresh outlook for 2025, indicating revenue and adjusted ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

Medicare covers Ozempic for Type 2 diabetes Medicare prescription drug plans might cover Ozempic, but only to treat diabetes. In 2021, Medicare spent over $2.6 billion to cover Ozempic prescriptions.

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Medicare doesn’t cover drugs when people take them off-label. For this reason, it doesn’t cover the pill form of semaglutide for weight loss.

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its 2025-26 budget plans.

A simple oversight could end up costing Danish pharma giant Novo Nordisk A/S (NYSE: NVO) billions in potential losses on its blockbuster weight-loss and diabetes drug, Ozempic.

Danish drugmaker Novo Nordisk has made billions of dollars from its GLP-1s, including pills and injectable drugs like Ozempic and Wegovy.